| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9226985 | Journal of Allergy and Clinical Immunology | 2005 | 28 Pages |
Abstract
The incorporation of measures of nasal inflammation in clinical trials has distinguished anti-inflammatory therapy from symptomatic therapy and has the potential to provide information about the efficacy of novel therapies for allergic rhinitis.
Keywords
ECPATSGM-CSFISHhpfiNOSGMAICAM-1EPXMIPSARgranulocyte/macrophage colony stimulating factorIn situ hybridizationinducible NO synthaseeosinophil peroxidaseEosinophilsNARESAllergic inflammationAmerican Thoracic Societyexhaled nitric oxideImmunohistochemistryinterleukinBiopsyTameParRhinitisPerennial allergic rhinitisepithelial cellsT-cellsSeasonal allergic rhinitisLavageLeukotrieneMast cellsRANTESIntercellular adhesion molecule 1high power fieldNitric oxideHistaminemacrophage inflammatory proteinEosinophil cationic proteinprostaglandinglycol methacrylatecytology
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Peter H. BSc (Hons), DM, FRCP, Carl G.A. PhD, Eli O. MD, Mikila R. PhD, Stephen R. MD, Philip E. MBBS, MRCP, FCCP,